Abeona Therapeutics Inc. (LON:0H7R)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Gene and Cell Therapies	3.50M
Gene and Cell Therapies Growth	147.52%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
United States	3.50M
United States Growth	147.52%